About this opportunity
McKesson Corporation lists this Research Nurse Blood Cancer opportunity in dallas, Texas. Review the employer’s description below for duties, qualifications and application requirements.
Job description
It\'s More Than a Career, It\'s a Mission.
Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.
Our Mission
People who live with cancer - those who work to prevent it, fight it, and survive it - are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world.
As the Research Nurse you are responsible for the day-to-day research nurse operations.
You will m entor, educate and train nurses.
You will p roblem-solve and triage clinical issues.
You will m onitor patient enrollment.
You will i dentify opportunities and develops action plans as necessary to increase patient accrual.
You will m eet regularly and as needed with physicians and Research Nurse Manager to assess performance.
You will s upport enrolling patients onto clinical trials through recruitment, screening and enrollment of eligible subjects according to protocol requirements.
You will e nsure the protection of study patients by timely adherence to pr otocol requirements/compliance and use the protocol as the only tool to screen, treat and follow patients.
You will review the study design and inclusion and exclusion criteria with physician and patient.
Attend weekly study status teleconferences
You will document the informed consent process accurately and have all parties fully execute the document including the HIPAA Aut horization. Completes screening and eligibility, inclusion/exclusion form s and stan dard enrollment forms.
You will ensure that patient documentation is completed at each clinic visit while in screening.
You will e nsure that all medications are approved by the registrar prior to initiating treatment to when changing medication regimens, such as crossover studies.
You will ensure that follow-up appointments, scans, or any related procedures are scheduled correctly according to protocol requirements.
Accurately calculate and document the BSA, creatinine clearance, urine protein: creatinine ratio or any other conversions needed per protocol
Accurately completes and submits follow-up SAE report to the Safety Department within the timeframe allotted by the Regulatory Department.
Accurately complete all data and query requests and submit with source documentation within the timeframe specified by the study manager
Document any interaction regarding the patient that occurs while the patient is enrolled on a protocol, including follow-up and survival (this includes home health intervention, pharmacies, study managers, physicians, and clinic colleagues)
You should have for this position:
An associate degree ; preferably a bachelor's degree
RN License
Knowledge of medical and research terminology
Knowledge of FDA Code of Federal Regulations and GCP
Knowledge of the clinical research processes
At least three years of oncology experience, five year are preferred
Blood Cancer experience is preferred
At least one year of experience in a research setting preferred
Research Certification (ACRP or CCRP) Preferred
About Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world's leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 850 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI's research network brings together more than 1,300 physicians who are enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S. Please click here to learn more about our research offerings.
We care about the well-being of the patients and communities we serve, and that starts with caring for our people. That's why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well-being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information regarding benefits through our parent company, McKesson, please click here.
As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long‑term incentive opportunities may be offered.
We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
#J-18808-Ljbffr
Worksite address
dallas, TX, 75215, US
Who can apply
Review the original listing for work authorization, qualifications and employer requirements.